Mineralys Therapeutics (MLYS) Update / Briefing June 17, 2025 08:00 AM ET Speaker0 Welcome to the Minerals Therapeutics Conference Call to Report Top Line Results from the EXPLORER CKD Phase II Trial. At this time, all participants are in listen only mode. After management completes their prepared remarks, we'll As a reminder, this conference call is being recorded. I would now like to turn the call over to John Conkleton, Chief Executive Officer of Mineralis Therapeutics. Thank you. You may now begin. Spea ...